NIDANHealthcare Service Provider
Nidan Laboratories & Healthcare Limited — Quarterly Results & Earnings
₹12.75
-4.14%
Profit Growth YoY30.00%Latest quarter
Sales Growth YoY24.60%Latest quarter
Sales CAGR 5Y2.76%5 year compound
Profit CAGR 5Y22.52%5 year compound
📋
Quarterly Performance
YoY Profit Growth+30.00%
🔥 Exceptional growth
YoY Sales Growth+24.60%
🔥 Exceptional growth
OPM 5Y Average
29.75%Operating profit margin
EPS Growth 5Y
14.48%Interest Coverage
2.52Higher = safer debt servicing
ROE
2.92%ROCE
6.17%💡
Growth Analysis
Nidan Laboratories & Healthcare Limited reported YoY profit growth of 30.00% and revenue growth of 24.60% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 2.76% and profits at 22.52% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Nidan Laboratories & Healthcare Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.